FDA, ARPA-H and XPRIZE map out the longevity regulatory frontier

Standard disease frameworks are meeting their match as pioneers lean on functional metrics and pragmatic stepping stone indications. The longevity landscape shifted in May at a landmark public meeting convened by the Reagan-Udall Foundation for the FDA. Co-sponsored by ARPA-H’s PROSPR program and the XPRIZE Foundation, the summit tackled the commercial ecosystem’s most stubborn bottleneck: […] The post FDA, ARPA-H and XPRIZE map out the longevity regulatory frontier appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.